Akinetic Mutism Caused by HIV-associated Progressive Multifocal Leukoencephalopathy was Successfully Treated with Mefloquine: A Serial Multimodal MRI Study

被引:14
作者
Naito, Kasane [1 ,2 ]
Ueno, Hiroki [1 ]
Sekine, Mayu [1 ,3 ]
Kanemitsu, Munekazu [1 ]
Ohshita, Tomohiko [1 ,4 ]
Nakamura, Takeshi [1 ]
Yamawaki, Takemori [1 ]
Matsumoto, Masayasu [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima 730, Japan
[2] Hiroshima City Hosp, Dept Neurol, Hiroshima, Japan
[3] Tokyo Saiseikai Cent Hosp, Dept Neurol, Tokyo, Japan
[4] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan
关键词
progressive multifocal leukoencephalopathy (PML); human immunodeficiency virus infection (HIV); highly active anti-retroviral therapy (HAART); mefloquine; proton magnetic resonance spectroscopy (H-1-MRS); apparent diffusion coefficient (ADC); ACTIVE ANTIRETROVIRAL THERAPY; SURVIVAL; SPECTROSCOPY;
D O I
10.2169/internalmedicine.51.6253
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a case of a patient with highly active anti-retroviral therapy-resistant human immunodeficiency virus (HIV)-associated progressive multifocal leukoencephalopathy (PML). The patient showed an improvement in imaging findings and clinical symptoms after mefloquine was introduced as an additional treatment. Serial assessment of white matter lesions was conducted by proton magnetic resonance spectroscopy (H-1-MRS) and diffusion-weighted imaging (DWI). As the clinical symptoms improved, the N-acetylaspartate/creatine ratio increased, the choline/creatine ratio decreased, and the elevated ADC value decreased. These concomitant changes suggested that H-1-MRS and DWI were useful for the assessment of the therapeutic effect on PML.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 26 条
[1]   Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA) [J].
Antinori, A ;
Cingolani, A ;
Lorenzini, P ;
Giancola, ML ;
Uccella, I ;
Bossolasco, S ;
Grisetti, S ;
Moretti, F ;
Vigo, B ;
Bongiovanni, M ;
Del Grosso, B ;
Arcidiacono, MI ;
Fibbia, GC ;
Mena, M ;
Finazzi, MG ;
Guaraldi, G ;
Ammassari, A ;
Monforte, AD ;
Cinque, P ;
De Luca, A .
JOURNAL OF NEUROVIROLOGY, 2003, 9 (Suppl 1) :47-53
[2]   Contract enhancement in progressive multifocal leukoencephalopathy:: a predictive factor for long-term survival? [J].
Arbusow, V ;
Strupp, M ;
Pfister, HW ;
Seelos, KC ;
Brückmann, H ;
Brandt, T .
JOURNAL OF NEUROLOGY, 2000, 247 (04) :306-308
[3]   Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy [J].
Berger, JR ;
Levy, RM ;
Flomenhoft, D ;
Dobbs, M .
ANNALS OF NEUROLOGY, 1998, 44 (03) :341-349
[4]   Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations [J].
Bergui, M ;
Bradac, GB ;
Oguz, KK ;
Boghi, A ;
Geda, C ;
Gatti, G ;
Schiffer, D .
NEURORADIOLOGY, 2004, 46 (01) :22-25
[5]   Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy [J].
Bossolasco, S ;
Calori, G ;
Moretti, F ;
Boschini, A ;
Bertelli, D ;
Mena, M ;
Gerevini, S ;
Bestetti, A ;
Pedale, R ;
Sala, S ;
Sala, S ;
Lazzarin, A ;
Cinque, P .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) :738-744
[6]   Identification and Characterization of Mefloquine Efficacy against JC Virus In Vitro [J].
Brickelmaier, Margot ;
Lugovskoy, Alexey ;
Kartikeyan, Ramya ;
Reviriego-Mendoza, Marta M. ;
Allaire, Norm ;
Simon, Kenneth ;
Frisque, Richard J. ;
Gorelik, Leonid .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :1840-1849
[7]   Use of Diffusion-Weighted Imaging to Evaluate the Initial Response of Progressive Multifocal Leukoencephalopathy to Highly Active Antiretroviral Therapy: Early Experience [J].
Buckle, C. ;
Castillo, M. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (06) :1031-1035
[8]   Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy [J].
Chang, L ;
Ernst, T ;
Tornatore, C ;
Aronow, H ;
Melchor, R ;
Walot, I ;
Singer, E ;
Cornford, M .
NEUROLOGY, 1997, 48 (04) :836-845
[9]  
Clinical Trials.gov, 1993, STUD EXPL EFF MEFL S
[10]  
Cuvinciuc V, 2010, AM J NEURORADIOL, V31, P69